News >

Treatment Modalities Evolving in Pancreatic Cancer

Angelica Welch
Published: Thursday, Oct 26, 2017

Mark J. Truty, MD

Mark J. Truty, MD
Pancreatic cancer is poised to be one of the leading causes of cancer-related death over the next 10 years, according to Mark J. Truty, MD. Though difficult to treat, there has been recent progress in the treatment of patients with this disease, he adds.

 on Gastrointestinal Cancers, Truty, an assistant professor of surgery at Mayo Clinic, discussed sequencing treatments and advances in imaging technology in pancreatic cancer.

OncLive: Please give an overview of your talk.

Truty: I spoke about the management of what we call nonmetastatic pancreas cancer. Pancreas cancer is a very deadly disease, and, as most people are aware, it is very stigmatic. The reason it is so deadly is that the majority of patients already present with metastases. Even when it is displayed on scans, most patients probably have micrometastatic disease. Therefore, I discussed the surgical management of these patients.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication